Announcements Trials
Browse Landscape

Phase

Phase 4 22Phase NA 15Phase 2 8Phase 3 6Phase 1/2 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Pain 1Neoplasms 1Dyspnea 1Chronic Pain 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 155Carboplatin 147Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 119Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Fentanyl × Clear all
NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Other

Dyspnea

NCT01248611 2014-05-12

NFCP1-2010

St. Olavs Hospital

Phase 1/2 Completed
10 enrolled

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡